Works matching IS 00316970 AND DT 2016 AND VI 72 AND IP 6

Results: 18

The pharmacokinetics of vancomycin in patients with severe acute pancreatitis.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 697, doi. 10.1007/s00228-016-2018-0

By:

He, Juan;
Mao, En-Qiang;
Feng, Jing;
Jiang, Hui-Ting;
Yang, Wan-Hua;
Chen, Er-Zhen

Publication type:

Article

CES1P1 variant −816A>C is not associated with hepatic carboxylesterase 1 expression and activity or antihypertensive effect of trandolapril.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 681, doi. 10.1007/s00228-016-2029-x

By:

Zhu, Hao-Jie;
Langaee, Taimour;
Gong, Yan;
Wang, Xinwen;
Pepine, Carl;
Cooper-DeHoff, Rhonda;
Johnson, Julie;
Markowitz, John

Publication type:

Article

A clinically relevant pharmacokinetic interaction between cyclosporine and imatinib.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 719, doi. 10.1007/s00228-016-2038-9

By:

Atiq, Ferdows;
Broers, Annoek;
Andrews, Louise;
Doorduijn, Jeanette;
Koch, Birgit;
Van Gelder, Teun;
Versmissen, Jorie

Publication type:

Article

Drug-related mortality among inpatients: a retrospective observational study.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 731, doi. 10.1007/s00228-016-2026-0

By:

Pardo Cabello, Alfredo José;
Del Pozo Gavilán, Esperanza;
Gómez Jiménez, Francisco Javier;
Mota Rodríguez, Carmen;
Luna Del Castillo, Juan de Dios;
Puche Cañas, Emilio

Publication type:

Article

Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 665, doi. 10.1007/s00228-016-2020-6

By:

Song, Ivy;
Weller, Steve;
Patel, Juhin;
Borland, Julie;
Wynne, Brian;
Choukour, Mike;
Jerva, Fred;
Piscitelli, Stephen

Publication type:

Article

Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 737, doi. 10.1007/s00228-016-2027-z

By:

Castañeda-Sanabria, Johann;
Hajage, David;
Jouan, Melisande;
Perozziello, Anne;
Tubach, Florence

Publication type:

Article

Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 645, doi. 10.1007/s00228-016-2030-4

By:

Vries Schultink, A.;
Suleiman, A.;
Schellens, J.;
Beijnen, J.;
Huitema, A.

Publication type:

Article

Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 747, doi. 10.1007/s00228-016-2028-y

By:

Frisk, Pia;
Sporrong, Sofia;
Ljunggren, Gunnar;
Wettermark, Björn;
Euler, Mia

Publication type:

Article

Efficacy and safety of empagliflozin as add-on to metformin for type 2 diabetes: a systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 655, doi. 10.1007/s00228-016-2010-8

By:

Zhong, Xiaoyan;
Lai, Dan;
Ye, Yun;
Yang, Xuping;
Yu, Bin;
Huang, Yilan

Publication type:

Article

Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 765, doi. 10.1007/s00228-016-2037-x

By:

Gadzhanova, Svetla;
Roughead, Elizabeth;
Bartlett, Louise

Publication type:

Article

Significant effect of age on docetaxel pharmacokinetics in Japanese female breast cancer patients by using the population modeling approach.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 703, doi. 10.1007/s00228-016-2031-3

By:

Onoue, Haruka;
Yano, Ikuko;
Tanaka, Atsuko;
Itohara, Kotaro;
Hanai, Akiko;
Ishiguro, Hiroshi;
Motohashi, Hideyuki;
Masuda, Satohiro;
Matsubara, Kazuo

Publication type:

Article

Elderly patients treated with psychotropic medicines admitted to hospital: associated characteristics and inappropriate use.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 755, doi. 10.1007/s00228-016-2032-2

By:

Vidal, Xavier;
Agustí, Antonia;
Vallano, Antoni;
Formiga, Francesc;
Moyano, Antonio;
García, Juana;
López-Soto, Alfonso;
Ramírez-Duque, Nieves;
Torres, Olga;
Barbé, José;
San-José, Antonio

Publication type:

Article

Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer's disease.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 711, doi. 10.1007/s00228-016-2033-1

By:

Coin, A;
Pamio, M;
Alexopoulos, C;
Granziera, S;
Groppa, F;
Rosa, G;
Girardi, A.;
Sergi, G.;
Manzato, E.;
Padrini, R

Publication type:

Article

Limited sampling strategies for once daily tacrolimus exposure monitoring.

Published in:

2016

By:

Carcas-Sansuán, Antonio

Publication type:

Letter

Response: Limited sampling strategies for once daily tacrolimus exposure monitoring.

Published in:

2016

By:

Moes, D.;
Swen, J.;
Bent, S.;
Straaten, T.;
Inderson, A.;
Olofsen, E.;
Verspaget, H.;
Guchelaar, H.;
Hartigh, J.;
Hoek, B.

Publication type:

Letter

The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 725, doi. 10.1007/s00228-016-2039-8

By:

El Messaoudi, S.;
Russel, F.;
Colbers, A.;
Bandell, C.;
Broek, P.;
Burger, D.;
Rongen, G.;
Riksen, N.

Publication type:

Article

Effects of the Chinese herbal formula 'Zuojin Pill' on the pharmacokinetics of dextromethorphan in healthy Chinese volunteers with CYP2D6*10 genotype.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 689, doi. 10.1007/s00228-016-2048-7

By:

Qiu, Furong;
Liu, Songcan;
Miao, Ping;
Zeng, Jin;
Zhu, Leilei;
Zhao, TongFang;
Ye, Yujie;
Jiang, Jian

Publication type:

Article

Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 6, p. 671, doi. 10.1007/s00228-016-2060-y

By:

Al-Aieshy, Fadiea;
Malmström, Rickard;
Antovic, Jovan;
Pohanka, Anton;
Rönquist-Nii, Yuko;
Berndtsson, Maria;
Al-Khalili, Faris;
Skeppholm, Mika

Publication type:

Article